Mtec project under the multi-topic request for project proposals (mtec-17-08-multi-topic). Prototype project 17-08-multi-topic-0245

Active Awarded Last action

Contract number
W81XWH2090006
Awardee
Awarding agency
Obligated
$28,183,958

Award facts

Contract value 86% obligated
$32,836,337.42 Current and potential, with all options
Completion date 99% complete
Current and potential, with all options
NAICS code
Not on record
Competition
Competed Program Solicitation
Pricing
Other
Place of performance
Summerville, SC 29486, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00009 $2,566,018
Supplemental Agreement for work within scope P00008 · A novel bacteriophage therapeutic for targeted treatment of staphylococcus aureus bacteremia, including drug resistant forms $0
Funding Only Action P00007 · 17-08-multitopic-0222. $409,111
Other Administrative Action P00005 · 17-08-mlti-topic-0222 $0
Supplemental Agreement for work within scope P00003 $5,303,394
Supplemental Agreement for work within scope P00004 · 17-08-multi-topic-0222 $3,442,435
Other Administrative Action P00002 · Increase in scope to project 17-08-multitopic-0222 $1,313,000
Original award $15,150,000

About this award

The Defense Health Agency awarded a $32.8 million Other Transaction Order to Medical Technology Enterprise Consortium for prototype development of a novel bacteriophage therapeutic targeting Staphylococcus aureus bacteremia, including drug-resistant forms, on February 28, 2024, under MTEC Project 17-08-MULTI-TOPIC-0245.

The award funds prototype development and is scheduled for ultimate completion on October 31, 2026. Place of performance is Summerville, SC. The therapeutic development represents one component of the Defense Health Agency's broader medical technology prototype acceleration mission through the MTEC consortium platform, which mobilizes academic and private sector partners to execute prototype development under Other Transaction Authority without traditional FAR procurement constraints.

Quick answers

Who was awarded contract W81XWH2090006?

W81XWH2090006 was awarded to Medical Technology Enterprise Consortium by Defense Health Agency (Department of Defense) on February 28, 2024.

How much is contract W81XWH2090006 worth?

The government has obligated $28,183,958 on W81XWH2090006. Its current value, with exercised options, is $32,836,337.

Is contract W81XWH2090006 an order under another contract?

Yes. W81XWH2090006 is an other transaction order under W81XWH1590001, an other transaction IDV.

Was contract W81XWH2090006 competed?

The extent of competition for W81XWH2090006 was competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award